Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of dexmedetomidine on postoperative nausea and vomiting
IRCT20230728058951N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in postoperative nausea and vomiting (PONV), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Postoperative nausea and vomiting incidence. Started Nov 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20230728058951N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230728058951N1.